Calcineurin inhibitor-free strategies for prophylaxis and treatment of GVHD in children with posterior reversible encephalopathy syndrome after stem cell transplantation.

about

Calcineurin inhibitor-free strategies for prophylaxis and treatment of GVHD in children with posterior reversible encephalopathy syndrome after stem cell transplantation.

Item

http://www.wikidata.org/entity/Q39247563

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Calcineurin inhibitor-free str ...... ter stem cell transplantation.

@en

Calcineurin inhibitor-free str ...... ter stem cell transplantation.

@nl

type

Item

label

Calcineurin inhibitor-free str ...... ter stem cell transplantation.

@en

Calcineurin inhibitor-free str ...... ter stem cell transplantation.

@nl

prefLabel

Calcineurin inhibitor-free str ...... ter stem cell transplantation.

@en

Calcineurin inhibitor-free str ...... ter stem cell transplantation.

@nl

P1476

Calcineurin inhibitor-free str ...... ter stem cell transplantation.

@en

P2093

Anat Yahel

http://www.w3.org/2001/XMLSchema#string

Aviva Krauss

http://www.w3.org/2001/XMLSchema#string

Isaac Yaniv

http://www.w3.org/2001/XMLSchema#string

Jerry Stein

http://www.w3.org/2001/XMLSchema#string

Orli Michaeli

http://www.w3.org/2001/XMLSchema#string

Osnat Konen

http://www.w3.org/2001/XMLSchema#string

Vered Shkalim-Zemer

http://www.w3.org/2001/XMLSchema#string

Yoel Levinsky

http://www.w3.org/2001/XMLSchema#string

P2860

PRES in Children Undergoing Hematopoietic Stem Cell or Solid Organ Transplantation

A reversible posterior leukoencephalopathy syndrome

Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema.

Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features.

Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities.

Treatment of refractory chronic GVHD with rituximab: a GITMO study.

Clinical and radiological spectrum of posterior reversible encephalopathy syndrome: does age make a difference?--A retrospective comparison between adult and pediatric patients.

Rituximab for steroid-refractory chronic graft-versus-host disease.

Interleukin-2 and regulatory T cells in graft-versus-host disease.

Drug interactions with the newer antiepileptic drugs (AEDs)--part 1: pharmacokinetic and pharmacodynamic interactions between AEDs.

P31

scholarly article

P356

10.1002/PBC.26531

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28417553

http://www.w3.org/2001/XMLSchema#string